Sjogren's syndrome co-existing with limited Wegener's granulomatosis [2]

Rheumatology

Volumn 39, Issue 7, 2000, Pages 805-806

  Karargyris, G ^a   Stamatopoulos, K ^a   Kittas, C ^a   Loukopoulos, D ^a   Vaiopoulos, G ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b University of Athens School of Medicine ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; METHYLPREDNISOLONE; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ADULT; BIOPSY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; FEMALE; HUMAN; LABORATORY TEST; LETTER; LUNG BIOPSY; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; WEGENER GRANULOMATOSIS; MIDDLE AGED; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; SJOGREN'S SYNDROME; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WEGENER GRANULOMATOSIS;

EID: 0033928845     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Nomenclature of systemic vasculitides: Proposal of an International Consensus Conference
2. Lumping or splitting auto-immune rheumatic disorders? Lessons from Sjogren's syndrome
3. Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjogren's syndrome
4. Wegener's granulomatosis presenting as major salivary gland enlargement
5. Salivary gland involvement in Wegener's granulomatosis. A case report and review of the literature
6. Ocular manifestations of classical and limited Wegener's granulomatosis
7. Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of the disease